The place of pharmacotherapy products in smoking cessation.
More people are giving up smoking with the support of nicotine replacement therapies or the former antidepressant bupropion than without, according to a growing body of evidence. This paper looks at the evidence supporting the use of pharmacotherapy products and explains the options available, as well as considering the nurse's role in helping people quit.
Jennifer
J
Percival
D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage* / Q000191:economics / Q000494:pharmacology*; D016642:Bupropion / Q000008:administration & dosage* / Q000191:economics / Q000494:pharmacology*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005731:Ganglionic Stimulants / Q000008:administration & dosage* / Q000191:economics / Q000494:pharmacology*; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage / Q000191:economics / Q000494:pharmacology*; D018579:Patient Selection; D016540:Smoking Cessation / Q000379:methods*; D014029:Tobacco Use Disorder / Q000188:drug therapy*
D018687:Antidepressive Agents, Second-Generation; D005731:Ganglionic Stimulants; D016642:Bupropion; D009538:Nicotine